GGCX Gene Vitamin K-Dependent Clotting Factors Combined Deficiency Type 1 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Bleeding Disorders
The GGCX Gene Vitamin K-Dependent Clotting Factors Combined Deficiency Type 1 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for hereditary bleeding disorders. This sophisticated genetic analysis utilizes next-generation sequencing technology to identify mutations in the GGCX gene that disrupt the proper functioning of vitamin K-dependent clotting factors. The test provides critical insights for patients experiencing unexplained bleeding tendencies and helps healthcare providers develop targeted treatment strategies.
What This Advanced Genetic Test Detects
This comprehensive DNA analysis specifically targets the GGCX gene, which encodes the enzyme gamma-glutamyl carboxylase. This enzyme plays a crucial role in the post-translational modification of vitamin K-dependent clotting factors, including Factors II, VII, IX, and X, as well as proteins C, S, and Z. The test identifies:
- Point mutations affecting enzyme function
- Insertions and deletions in the GGCX gene
- Missense and nonsense mutations
- Regulatory region variations
- Compound heterozygous mutations
Who Should Consider This Genetic Test
This specialized genetic analysis is recommended for individuals presenting with:
- Unexplained bleeding episodes or excessive bleeding after minor injuries
- Easy bruising without apparent cause
- Family history of bleeding disorders
- Abnormal coagulation test results without clear diagnosis
- Multiple clotting factor deficiencies detected in laboratory testing
- Poor response to vitamin K supplementation
- Neonates with unexplained bleeding complications
Significant Benefits of Genetic Testing
Undergoing the GGCX gene analysis provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Confirms the specific genetic cause of bleeding disorders
- Personalized Treatment: Enables targeted therapy based on genetic findings
- Family Planning: Provides information for genetic counseling and family planning decisions
- Proactive Management: Allows for early intervention and preventive measures
- Comprehensive Understanding: Explains the underlying mechanism of multiple clotting factor deficiencies
Understanding Your Genetic Test Results
Your test results will be carefully interpreted by our team of genetic specialists and hematologists. A positive result indicates the presence of pathogenic mutations in the GGCX gene, confirming the diagnosis of vitamin K-dependent clotting factors combined deficiency type 1. A negative result suggests that mutations in the GGCX gene are not responsible for your symptoms, though other genetic or acquired causes may need investigation. All results include detailed explanations and recommendations for next steps, including consultation with hematology specialists.
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Take Control of Your Health Today
Don’t let unexplained bleeding symptoms remain a mystery. Our advanced GGCX gene testing provides the answers you need for proper diagnosis and effective management. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are ready to help you understand your risk and take proactive steps toward better health management.
